Libera Bio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface, transmembrane or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.
<< Fraud Alert for Potential Candidates >>
At Libera Bio, your personal information and online safety are our top priorities.
• Candidates should apply exclusively through our official webpage at https://www.liberabio.com/contact/ or rrhh@liberabio.com.
• If we collaborate with recruiters, they will always represent well-established and reputable firms.
• We will NEVER ask for payments, financial account details, or sensitive data like social security numbers during the recruitment process.
Stay safe
Company Details
- Employees
- 10
- Founded
- -
- Address
- Santiago De Compostela, Galicia 15782, Es
- Co****@****Bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- liberabio.com
- Keywords
- Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, Cytotoxics.
- HQ
- Santiago de Compostela, Galicia
Liberabio Questions
Liberabio's website is liberabio.com
Liberabio's LinkedIn profile is https://www.linkedin.com/company/liberabio
Liberabio has
10 employees.
View email and phone details for 10
employees at Liberabio.
Liberabio's industry is
Biotechnology Research
Liberabio's top competitors are
Celtarys Research,
Bflow,
Fuse Vectors,
Glyprovac,
Theriva Biologics, Inc.,
Serendip Innovations,
Atlyphe Ag,
Diversa Technologies,
Ikarovec,
Gene Vector.
Liberabio's support email address is Contact@LiberaBio.com
Liberabio's categories are Biotechnology Research
Liberabio's founding year is 2018
